Expanding Our Knowledge of Molecular Pathogenesis in Histiocytoses

Author:

Crowley Helena M.1,Georgantzoglou Natalia2,Tse Julie Y.3,Williams Erik A.3,Mata Douglas A.3,Martin Stuart S.4,Guitart Joan5,Bridge Julia A.67,Linos Konstantinos8

Affiliation:

1. Division of Pediatric Surgery and Urology, University of Maryland Children’s Hospital

2. Department of Pathology and Laboratory Medicine, Dartmouth Hitchcock Medical Center, Lebanon, NH

3. Foundation Medicine Inc., Cambridge, MA

4. Department of Pharmacology and Physiology, University of Maryland School of Medicine, Baltimore, MD

5. Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, IL

6. Division of Molecular Pathology, ProPath, Dallas, TX

7. Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE

8. Department of Pathology & Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY

Abstract

The histiocytoses comprise a histopathologically and clinically diverse group of disorders bearing recurrent genomic alterations, commonly involving the BRAF gene and mitogen-activated protein kinase pathway. In the current study, a novel CLTC::SYK fusion in 3 cases of a histopathologically distinct histiocytic neoplasm arising as solitary soft tissue lesions in children identified by next-generation sequencing and fluorescence in situ hybridization is described. Morphologically, all 3 neoplasms were composed of sheets of cells with round-oval nuclei and vacuolated eosinophilic cytoplasm but, in contrast to classic juvenile xanthogranuloma (JXG), Touton giant cells were absent. A separate cohort of classic JXG cases subsequently profiled by fluorescence in situ hybridization were negative for the presence of a CLTC::SYK fusion suggesting that CLTC::SYK fusion-positive histiocytoma is genetically and histologically distinct from JXG. We postulate that the CLTC::SYK fusion leads to aberrant activation of the SYK kinase, which is involved in variable pathways, including mitogen-activated protein kinase. The identification of a novel CLTC::SYK fusion may pave the way for the development of targeted therapeutic options for aggressive disease.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pathology and Forensic Medicine,Surgery,Anatomy

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3